OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age
Mirna Chehade, Evan S. Dellon, Jonathan M. Spergel, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 24, pp. 2239-2251
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis
Evan S. Dellon, Amanda B. Muir, David A. Katzka, et al.
The American Journal of Gastroenterology (2025) Vol. 120, Iss. 1, pp. 31-59
Closed Access | Times Cited: 7

An update on the diagnosis and management of non‐IgE‐mediated food allergies in children
Rosan Meyer, Antonella Cianferoni, Marta Vázquez‐Ortiz
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 3
Closed Access | Times Cited: 1

Letter: Disappearing Microbe, Emerging Disease? Nuancing the Protective Effects of Helicobacter pylori Against Eosinophilic Oesophagitis
Enzo Emanuele, Piercarlo Minoretti
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1

Roads to remission: evolving treatment concepts in type 2 inflammatory diseases
Marek Lommatzsch, Katharina Blümchen, Lisa A. Beck, et al.
EClinicalMedicine (2025) Vol. 80, pp. 103050-103050
Open Access

Eosinophile Ösophagitis
Thomas Greuter
Deleted Journal (2025)
Closed Access

Modern Possibilities of Usage Dupilumab in Children
Anna A. Kosova, Anastasiya V. Fayans, Aishan Е. Ibaduiiaeva, et al.
Педиатрическая фармакология (2025) Vol. 21, Iss. 6, pp. 520-533
Open Access

Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
Mohammed Hasosah, Ghassan Sukkar, Asharf AlSahafi, et al.
BMC Pediatrics (2025) Vol. 25, Iss. 1
Open Access

Diagnosis and Management of Long-term Gastrointestinal Complications in Pediatric Esophageal Atresia/Tracheoesophageal Fistula
Delia O'Shea, Eric Quinn, William Middlesworth, et al.
Current Gastroenterology Reports (2025) Vol. 27, Iss. 1
Closed Access

Real-world Effectiveness of Dupilumab in Eosinophilic Esophagitis
Archit Garg, Vishali Moond, Sugirdhana Velpari, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access

Eosinophilic esophagitis: Prevalence, diagnosis, and treatment in childhood and adulthood
André Hoerning, Jens-Oliver Steiß, Ahmed Madisch, et al.
Deutsches Ärzteblatt international (2025)
Closed Access

A comprehensive guide to food allergy management for the general pediatrician
Ashley Sang Eun Lee, Sara Dehbozorgi, Michèle Beaudoin, et al.
Current problems in pediatric and adolescent health care (2025), pp. 101729-101729
Closed Access

Protocolo diagnóstico y terapéutico de la esofagitis eosinofílica
I. Roibás Veiga, P. Méndez Brea, T. González Vidal, et al.
Medicine - Programa de Formación Médica Continuada Acreditado (2025) Vol. 14, Iss. 29, pp. 1775-1780
Closed Access

Circulating Food Allergen‐Specific Antibodies, Beyond IgG4, Are Elevated in Eosinophilic Esophagitis
Manal Bel Imam, Sayuri Iwasaki, Sophieke Lems, et al.
Clinical & Experimental Allergy (2025)
Closed Access

New Therapeutic Challenges in Pediatric Gastroenterology: A Narrative Review
Valeria Dipasquale, Claudio Romano
Healthcare (2025) Vol. 13, Iss. 8, pp. 923-923
Open Access

The role of dupilumab in the treatment of eosinophilic esophagitis
Erin Syverson, Eitan Rubinstein, John J. Lee, et al.
Immunotherapy (2024) Vol. 16, Iss. 13, pp. 845-852
Closed Access | Times Cited: 2

Real-world effectiveness and use of dupilumab in eosinophilic esophagitis
Michelle Russin, Joan W. Chen, Joel H. Rubenstein, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 2

From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis
Alberto Barchi, Francesco Vito Mandarino, Mona‐Rita Yacoub, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1080-1080
Open Access | Times Cited: 1

Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis
Maurizio Mennini, Pasquale Parisi, Giovanni Di Nardo
New England Journal of Medicine (2024) Vol. 391, Iss. 11, pp. 1065-1068
Closed Access | Times Cited: 1

Understanding tissue injury and remodelling in eosinophilic oesophagitis: development towards personalised medicine
Giovanni Santacroce, Carlo Maria Rossi, Marco Vincenzo Lenti, et al.
Gut (2024), pp. gutjnl-333994
Closed Access | Times Cited: 1

Eosinophilic oesophagitis in adults: from symptoms to therapeutic options
Carlo Maria Rossi, Marco Vincenzo Lenti, Giovanni Santacroce, et al.
Internal and Emergency Medicine (2024)
Closed Access | Times Cited: 1

Unmasking the Culprits in Eosinophilic Esophagitis Pathogenesis
Benjamin L. Wright
New England Journal of Medicine (2024) Vol. 390, Iss. 24, pp. 2321-2322
Closed Access

Page 1 - Next Page

Scroll to top